Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT04504864

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04504864
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04504864. Randomized; double masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2022-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
Acronym
AIM
Intervention (Drug)
low-dose aspirin
Intervention (Drug)
conventional-does aspirin
Lead sponsor
Xijing Hospital (class: other)
Collaborator
Shaanxi Provincial People's Hospital (class: other)
Collaborator
The First Affiliated Hospital of Jiaotong University (class: not stated)
Collaborator
Tang-Du Hospital (class: other)
Collaborator
First Affiliated Hospital Xi'an Jiaotong University (class: other)
Collaborator
Xi'an Central Hospital (class: other)
Collaborator
Xiangyang Central Hospital (class: other)
Collaborator
Baoji Central Hospital (class: other)

Record details

Record id
cardio:ct-nct04504864
Content hash
1ff81c2edcd7fc2b31a694b03ebb7fed1c99ceeb70632fc44e122400db41a37b